Nektar Therapeutics (NKTR)
68.55
-0.94
(-1.35%)
USD |
NASDAQ |
May 21, 16:00
68.55
0.00 (0.00%)
After-Hours: 19:59
Nektar Therapeutics Accounts Payable (Quarterly) : 10.03M for March 31, 2026
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Eli Lilly & Co. | 5.029B |
| Aquestive Therapeutics, Inc. | 11.89M |
| Boston Scientific Corp. | 1.141B |
| Esperion Therapeutics, Inc. | 68.41M |
| Corcept Therapeutics, Inc. | 33.31M |